Standard Glass Lining Technology Limited – Globe Capital Market LTD.
Standard Glass Lining Technology Limited
Closed
Price Band
₹133 to ₹140 per share
IPO Issue Period
January 6, 2025 to January 8, 2025
Issue Size
₹410.05 Cr
Face value
₹10 per share
Fresh issue
₹ 210.00 Cr
Offer for sale
₹200.05 Cr
Minimum Shares for Retail
107 Shares
Listing on
BSE, NSE
Issue Type
Book Built Issue IPO
Registrar to the Issue
Kfin Technologies Limited
Tentative Listing Date
Monday, January 13, 2025
QIB
50%
NII
15%
Retail
35%

Iifl Securities Ltd
Motilal Oswal Investment Advisors Limited

Standard Glass Lining Technology Limited is a leading manufacturer of specialized engineering equipment for the pharmaceutical and chemical sectors in India, ranking among the top five based on Revenue for Fiscal 2024. With comprehensive in-house capabilities, the company designs, engineers, and manufactures essential equipment, including Reaction Systems and Storage, Separation, and Drying Systems. It is a top supplier of glass-lined and nickel alloy equipment, as well as PTFE lined pipelines. Over the past three fiscal years, it has been the fastest-growing company in its industry, supplying over 11,000 products and serving a diverse customer base, including 30 of the 80 pharmaceutical and chemical companies in the NSE 500 index.

For the year/period ended (Rs. in Cr.)

FY24 FY23 FY22
Total Revenue 543.67 497.59 240.19
Profit After Tax 60.05 53.37 25.20
EPS 3.52 3.49 2.22
OPM (%) 17.46% 17.24% 16.85%
PATM (%) 10.92% 10.67% 10.43%

 

For year/ period ended ( in Cr.)

Company Name Market Cap (Cr.) Price P/BV P/E Sales (Cr.)
FY23
Net Profits(Cr.)
FY23
Standard Glass Lining Technology Limited 2792.88 140.00 5.70 38.50 543.67 60.05
GMM Pfaudler Ltd. 5306.98 1180.45 5.77 31.05 3446.48 174.10
HLE Glascoat Ltd. 2496.47 365.70 6.69 93.88 959.90 44.51
Praj Industries Ltd. 15536.80 845.25 7.68 34.56 3391.35 283.39
Thermax Ltd. 46811.15 3928.55 10.65 73.21 9323.46 643.19

 

 

 

  • Innovative Technology
  • Experienced Management Team
  • Diverse Product Portfolio
  • Strong Customer Relationships
  • Quality Assurance
  • Strategic Partnerships
  • Market Presence
  • In-house Research and Development
  • Capital Expenditure
  • Working Capital Requirements
  • Debt Repayment
  • Brand Development
  • General Corporate Purposes
  • Research and Development

The company is one of the leading manufacturers of engineering equipment for the pharmaceutical and chemical sectors in India. It also provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for pharmaceutical and chemical manufacturers. At the upper price band of INR 140, the company is expected to list with a PE ratio of 38.5 and a PB ratio of 5.7. Therefore, we recommended to “Subscribe” the IPO for long-term gains.

Be a Part of IPO Success Stories!

Never Miss IPO Investment